The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Assessing and Improving Value in Cancer Care: Workshop Summary
Appendix A
Workshop Agenda
Assessing and Improving Value in Cancer Care
A National Cancer Policy Forum Workshop
Monday and Tuesday, February 9 and 10, 2009
NAS Lecture Room
National Academy of Sciences Building
2100 C Street, NW
Washington, DC
DAY ONE
8:00 a.m.
Welcome, Introductory Remarks: What Is Value inCancer Care? Why Is It Important?
Scott D. Ramsey, Fred Hutchinson Cancer Research Center
8:20
Physician–Patient Communication and Its Influenceon Value
Moderator: Allen S. Lichter, American Society of ClinicalOncology
8:25
Inside the Physician–Patient Discussion in Cancer Care
Speaker: Anthony Back, University of Washington
8:55
Invited Comments from Diane Blum, CancerCare
9:00
Can We Communicate Effectively with Cancer PatientsAbout the Benefits and Risks of Cancer Treatments?
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole. Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 125
Assessing and Improving Value in Cancer Care: Workshop Summary
Appendix A
Workshop Agenda
Assessing and Improving Value in Cancer Care
A National Cancer Policy Forum Workshop
Monday and Tuesday, February 9 and 10, 2009
NAS Lecture Room
National Academy of Sciences Building
2100 C Street, NW
Washington, DC
DAY ONE
8:00 a.m.
Welcome, Introductory Remarks: What Is Value in Cancer Care? Why Is It Important?
Scott D. Ramsey, Fred Hutchinson Cancer Research Center
8:20
Physician–Patient Communication and Its Influence on Value
Moderator: Allen S. Lichter, American Society of Clinical Oncology
8:25
Inside the Physician–Patient Discussion in Cancer Care
Speaker: Anthony Back, University of Washington
8:55
Invited Comments from Diane Blum, CancerCare
9:00
Can We Communicate Effectively with Cancer Patients About the Benefits and Risks of Cancer Treatments?
Speaker: Peter A. Ubel, University of Michigan
OCR for page 126
Assessing and Improving Value in Cancer Care: Workshop Summary
9:30
Invited Comments from Mary McCabe, Memorial Sloan-Kettering Cancer Survivorship Program
9:35
Therapy for Advanced-Stage Cancer: What Do Patients Want and Expect?
Speaker: Robert Erwin, Marti Nelson Cancer Foundation
10:05
Invited Comments from Ellen Stovall, National Coalition for Cancer Survivorship
10:10
Discussion
10:40
10-Minute Break
10:50
Generating Evidence About Effectiveness and Value
Moderator: Steven B. Cohen, Agency for Healthcare Research and Quality
10:55
FDA Perspectives on Evidence for Regulatory Approval in Cancer
Speaker: Janet Woodcock, Food and Drug Administration
11:25
What Constitutes Reasonable Evidence of Efficacy and Effectiveness?
Speaker: Daniel J. Sargent, Mayo Clinic
11:55
Discussion
12:25 p.m.
Lunch
1:00
Value and the Oncology Market
Moderator: Jeffrey C. Lerner, ECRI Institute
1:05
Drug Pricing and Value in Oncology vs. Other Areas in Medicine
Speaker: Patricia M. Danzon, University of Pennsylvania
1:35
Industry Perspective on Pharmaceutical Pricing in Oncology
Speaker: Greg Rossi, Genentech, Inc.
OCR for page 127
Assessing and Improving Value in Cancer Care: Workshop Summary
2:05
Cost Implications: Strategies to Enhance Value in Oncology
Speaker: Deborah Schrag, Dana-Farber/Harvard Cancer Center
2:35
Discussion
3:20
10-Minute Break
3:30
Value in Cancer Practice: Health Insurer Perspectives
Moderator: Scott D. Ramsey, Fred Hutchinson Cancer Research Center
3:35
Oncologists’ Perception of Value in Oncology
Speaker: Peter J. Neumann, Tufts Medical Center
4:05
Paying for New Cancer Treatments: Rights and Responsibilities of Health Insurers
Speaker: Lee Newcomer, United Healthcare
4:35
European Experience and Perspectives on Evaluating Value for Oncology Products
Speaker: Michael Drummond, Centre for Health Economics, University of York
5:05
Discussion
5:50
Adjourned for the day
DAY TWO
8:00 a.m.
Ethical Issues for Value-Based Decision Making in Oncology
Moderator: Harold L. Moses, Vanderbilt-Ingram Cancer Center
8:05
Ethical Issues When Considering Insurance Coverage Based on Value in the Treatment of Cancer
Speaker: Dan W. Brock, Harvard Medical School
OCR for page 128
Assessing and Improving Value in Cancer Care: Workshop Summary
8:35
Patient–Physician Communication on Therapy Options for Cancer: Ethical Issues
Speaker: Neil S. Wenger, University of California, Los Angeles
9:05
Discussion
9:35
10-Minute Break
9:45
Improving Value in Oncology Practice: Ways Forward
Moderator: Lou Garrison, University of Washington
9:50
Value-Based Insurance Design—Initiatives Outside of Oncology
Speaker: Michael Chernew, Harvard Medical School
10:20
Generating Evidence of Value Post-FDA Approval: Is There a Role for Health Insurers?
Speaker: Sean R. Tunis, Center for Medical Technology Policy
10:50
Are There Ways to Improve the Value of Cancer Care That May Work at the Bedside?
Speaker: Thomas J. Smith, Virginia Commonwealth University
11:20
Discussion
WORKING LUNCH
12:05 p.m.
Toward a Shared Understanding of Value: Can We Agree, and Does Perspective Matter?
Moderator: Peter Bach, Memorial Sloan-Kettering Cancer Center
Panel: All Moderators
1:30
Meeting Adjourned
